Previous studies indicated that serum levels of CCL5 were significantly increased in multiple sclerosis (MS) patients (13) and in experimental autoimmune encephalomyelitis (EAE) animals (14). This evidence concerns the gene CCL5 and experimental autoimmune encephalomyelitis.